Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

IMUGENE LIMITED Capital/Financing Update 2022

Jun 7, 2022

65124_rns_2022-06-07_0e12e181-3f7a-4f1f-bf62-4ae56dc78f80.pdf

Capital/Financing Update

Open in viewer

Opens in your device viewer

==> picture [117 x 42] intentionally omitted <==

8 June 2022

ASX ANNOUNCEMENT

ASX: IMU

Notice Under Section 708A(5)(e) of the Corporations Act 2001

Type Shares
Class/description Ordinary
ASX code IMU
Date of issue 7 June 2022 8 June 2022
Number issued & 10,000,000 6,250,000
Issue price per security @ $0.045 ea. @ $0.04 ea.
Shares issued upon the exercise of unlisted options

Imugene Limited (ASX: IMU) (‘IMU’ or the ‘Company’) gives notice under section 708A(5)(e) of the Corporations Act 2001 (Cth) (the "Corporations Act") that:

  1. the abovementioned ordinary shares were issued without disclosure under Part 6D.2 of the Corporations Act;

  2. as at the date of this notice the Company has complied with:

  3. (i) the provisions of Chapter 2M of the Corporations Act as they apply to the Company; and

  4. (ii) sections 674 and 674A of the Corporations Act; and

  5. as at the date of this notice there is no "excluded information" (as defined in sections 708A(7) and 708A(8) of the Corporations Act) which is required to be disclosed by the Company.

Nathan Jong Joint Company Secretary

[email protected]

IMUGENE LIMITED ACN 009 179 551

WWW.IMUGENE.COM